Sequence, genetics and serology of a new HLA-B allele: B*4903

被引:6
作者
Darke, C [1 ]
Street, J [1 ]
Guttridge, MG [1 ]
机构
[1] Welsh Blood Serv, Welsh Transplantat & Immunogenet Lab, Pontyclun CF72 9WB, Wales
来源
TISSUE ANTIGENS | 2001年 / 57卷 / 05期
关键词
HLA-B*4903; HLA-B49; HLA class I specificity;
D O I
10.1034/j.1399-0039.2001.057005478.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A new HLA-Ballele-B*4903-was detected by the polymerase chain reaction using sequence-specific priming (PCR-SSP), in a Caucasoid bone marrow panel donor, that differs from B*4901 by 8 nucleotides at positions 141, 142, 144, 165, 167, 193, 206 and 213 in exon 2. These substitutions all occur in HLA-B*51 and B*52 alleles and encode 4 amino acid substitutions at positions 21 (Thr to Ala), 32 (Leu to Gln), 41 (Thr to Ala) and 45 (Lys to Thr). This suggests that B*4903 occurred following a gene conversion-like event involving B*4901 and probably a B*51 allele. HLA-B*4903 was identified on a haplotype with: HLA-A+0201; Cw*07; DRB1*1302/34; DRB3*0301; DQA1*0102; DQB1*0604; BfS; C4A3; C4BQ0 and encodes a unique serological specificity which was characterised by the reactivity of 55 antisera directed towards at least four predicted epitopes. No further examples of B*4903 were found in 15,796 consecutive HLA PCR-SSP typed donors from the Welsh Bone Marrow Donor Registry, indicating that this allele has a phenotype frequency of <0.01% and a gene frequency of <0.00004.
引用
收藏
页码:478 / 480
页数:3
相关论文
共 15 条
[1]   2 SUBTYPES OF BFF BY ISOELECTROFOCUSING - DIFFERENTIAL LINKAGE TO OTHER HLA MARKERS [J].
ABBAL, M ;
THOMSEN, M ;
CAMBONTHOMSEN, A ;
ARCHAMBEAU, J ;
CALOT, M ;
FATHALLAH, D .
HUMAN GENETICS, 1985, 69 (02) :181-183
[2]   INHERITED STRUCTURAL POLYMORPHISM IN HUMAN C2 - EVIDENCE FOR GENETIC LINKAGE BETWEEN C2 AND BF [J].
ALPER, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (04) :1111-1115
[3]   INHERITED STRUCTURAL POLYMORPHISM OF THE 4TH COMPONENT OF HUMAN-COMPLEMENT [J].
AWDEH, ZL ;
ALPER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3576-3580
[4]   Nomenclature for factors of the HLA system, 1998 [J].
Bodmer, JG ;
Marsh, SGE ;
Albert, ED ;
Bodmer, WF ;
Bontrop, RE ;
Dupont, B ;
Erlich, HA ;
Hansen, JA ;
Mach, B ;
Mayr, WR ;
Parham, P ;
Petersdorf, EW ;
Sasazuki, T ;
Schreuder, GMT ;
Strominger, JL ;
Svejgaard, A ;
Terasaki, PI .
TISSUE ANTIGENS, 1999, 53 (04) :407-446
[5]   Dimorphic primers derived from intron I for use in the molecular typing of HLA-B alleles [J].
Cereb, N ;
Yang, SY .
TISSUE ANTIGENS, 1997, 50 (01) :74-76
[6]   HLA-B*4703: sequence confirmation, serology and distribution [J].
Darke, C ;
Guttridge, MG ;
Street, J ;
Thompson, J ;
Thomas, M .
TISSUE ANTIGENS, 1999, 53 (06) :586-590
[7]   An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision [J].
Darke, C .
BONE MARROW TRANSPLANTATION, 2000, 25 (07) :771-777
[8]   HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales [J].
Darke, C ;
Guttridge, MG ;
Thompson, J ;
McNamara, S ;
Street, J ;
Thomas, M .
EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1998, 15 (02) :69-83
[9]  
DARKE C, 1983, TISSUE ANTIGENS, V21, P281
[10]  
DARKE C, 1980, TISSUE ANTIGENS, V15, P75